PMD200
PMD200 is a medical device with 6 clinical trials. Historical success rate of 50.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
50.0%
3 of 6 finished
50.0%
3 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impact of NOL Intraoperative Guided Fentanyl Analgesia vs SCC for Elective Major Abdominal Surgery
Nociception-Level (NOL) for the Assessment of Pain in Patient Unable to Self-Report
Performance Assessment Of The PMD-200 In Subjects With Degenerative Lumbar Spine Disease Who Requires Surgical Procedure
Performance Assessment of the PMD-200 in Subjects at Neurointensive Care Unit
Performance Assessment of the PMD-200 in Subjects Requiring Surgery Under General Anesthesia
Clinical Trials (6)
Impact of NOL Intraoperative Guided Fentanyl Analgesia vs SCC for Elective Major Abdominal Surgery
Nociception-Level (NOL) for the Assessment of Pain in Patient Unable to Self-Report
Performance Assessment Of The PMD-200 In Subjects With Degenerative Lumbar Spine Disease Who Requires Surgical Procedure
Performance Assessment of the PMD-200 in Subjects at Neurointensive Care Unit
Performance Assessment of the PMD-200 in Subjects Requiring Surgery Under General Anesthesia
Evaluation of Medasense's PMD-200 During Surgery and Post Anesthesia Care
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6